Acetazolamide acts directly on the human skeletal muscle chloride channel

Muscle and Nerve

Volumn 34, Issue 3, 2006, Pages 292-297

  Eguchi, Hiroto ^a   Tsujino, Akira ^a   Kaibara, Muneshige ^a   Hayashi, Hideki ^a   Shirabe, Susumu ^a   Taniyama, Kohtaro ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Acetazolamide; CIC 1; Myotonia; Open probability; Whole cell recording

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CHLORIDE CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CHLORIDE CHANNEL;

ACIDIFICATION; ARTICLE; ATAXIA; CHANNEL GATING; CHLORIDE CONDUCTANCE; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; MAMMAL CELL; MEMBRANE STEADY POTENTIAL; MUSCLE WEAKNESS; MYOTONIA; NEUROMUSCULAR DISEASE; PIPETTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ACETAZOLAMIDE; ANTI-ARRHYTHMIA AGENTS; ANTICONVULSANTS; BUFFERS; CELL LINE; CHLORIDE CHANNELS; HUMANS; ION CHANNEL GATING; KIDNEY; MEMBRANE POTENTIALS; MEXILETINE; MUSCLE, SKELETAL; PATCH-CLAMP TECHNIQUES; PHENYTOIN; PROTONS; TRANSFECTION;

EID: 33748070834     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20585     Document Type: Article

References (13)

1. Cannon SC. Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci 1996;19:3-10.
2. Duffield M, Rychkov G, Bretag A, Roberts M. Involvement of helices at the dimmer interface in ClC-1 common gating. J Gen Physiol 2003;121:149-161.
3. Dutzler R, Campbell EB, MacKinnon R. Gating the selectivity filter in CIC chloride channels. Science 2003;300:108-112.
4. Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000;80:681-715.
5. Griggs RC, Moxley RT III, Riggs JE, Engel WK. Effects of acetazolamide on myotonia. Ann Neurol 1978;3:531-537.
6. Kaibara M, Ishihara K, Doi Y, Hayashi H, Ehara T, Taniyama K. Identification of human Kir2.2 (KCNJ12) gene encoding functional inward rectifier potassium channel in both mammalian cells and Xenopus oocytes. FEBS Lett 2002;531:250-254.
7. Leniger T, Wiemann M, Bingmann D, Widman G, Hufnagel A, Bonnet U. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 2002;43:469-474.
8. Links TP, Zwarts MJ, Oosterhuis HJ. Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide. J Neurol Neurosurg Psychiatry 1988;51:1142-1145.
9. Munsch T, Pape HC. Upregulation of the hyperpolarization-activated cation current in rat thalamic relay neurones by acetazolamide. J Physiol (Lond) 1999;519:505-514.
10. Rychkov GY, Pusch M, Astill DS, Roberts ML, Jentsch TJ, Bretag AH. Concentration and pH dependence of skeletal muscle chloride channel CIC-1. J Physiol (Lond) 1996;497:423-435.
11. Sterling D, Brown NJ, Supuran CT, Casey JR. The functional and physical relationship between the DRA bicarbonate transporter and carbonic anhydrase II. Am J Physiol Cell Physiol 2002;283:C1522-C1529.
12. 2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol 2000;48:304-312.
13. Zasorin NL, Baloh RW, Myers LB. Acetazolamide-responsive episodic ataxia syndrome. Neurology 1983;33:1212-1214.